Publications by authors named "Frans Maas"

Claim this Profile
I
Increased Coexpression of PD-1, TIGIT, and KLRG-1 on Tumor-Reactive CD8 T Cells During Relapse after Allogeneic Stem Cell Transplantation.
Tim J A Hutten, Wieger J Norde, Rob Woestenenk, Ruo Chen Wang, Frans Maas

Biol Blood Marrow Transplant· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decitabine enhances targeting of AML cells by CD34 progenitor-derived NK cells in NOD/SCID/IL2Rg mice.
Jeannette Cany, Mieke W H Roeven, Janneke S Hoogstad-van Evert, Willemijn Hobo, Frans Maas

Blood· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful Transfer of Umbilical Cord Blood CD34 Hematopoietic Stem and Progenitor-derived NK Cells in Older Acute Myeloid Leukemia Patients.
Harry Dolstra, Mieke W H Roeven, Jan Spanholtz, Basav N Hangalapura, Marleen Tordoir, Frans Maas

Clin Cancer Res· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Aryl Hydrocarbon Receptor Antagonist StemRegenin1 Improves In Vitro Generation of Highly Functional Natural Killer Cells from CD34(+) Hematopoietic Stem and Progenitor Cells.
Mieke W H Roeven, Soley Thordardottir, Arwa Kohela, Frans Maas, Frank Preijers

Stem Cells Dev· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy.
Anniek B van der Waart, Noortje M P van de Weem, Frans Maas, Cynthia S M Kramer, Michel G D Kester

Blood· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of dendritic cells pulsed with MAGE3, Survivin and B-cell maturation antigen mRNA for vaccination of multiple myeloma patients.
Willemijn Hobo, Leonie Strobbe, Frans Maas, Hanny Fredrix, Annelies Greupink-Draaisma

Cancer Immunol Immunother· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homing characteristics of donor T cells after experimental allogeneic bone marrow transplantation and posttransplantation therapy for multiple myeloma.
Robbert van der Voort, Thomas J H Volman, Viviènne Verweij, Peter C M Linssen, Frans Maas

Biol Blood Marrow Transplant· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B and T lymphocyte attenuator mediates inhibition of tumor-reactive CD8+ T cells in patients after allogeneic stem cell transplantation.
Willemijn Hobo, Wieger J Norde, Nicolaas Schaap, Hanny Fredrix, Frans Maas

J Immunol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1/PD-L1 interactions contribute to functional T-cell impairment in patients who relapse with cancer after allogeneic stem cell transplantation.
Wieger J Norde, Frans Maas, Willemijn Hobo, Alan Korman, Michael Quigley

Cancer Res· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
siRNA silencing of PD-L1 and PD-L2 on dendritic cells augments expansion and function of minor histocompatibility antigen-specific CD8+ T cells.
Willemijn Hobo, Frans Maas, Niken Adisty, Theo de Witte, Nicolaas Schaap

Blood· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Partial T cell-depleted allogeneic stem cell transplantation following reduced-intensity conditioning creates a platform for immunotherapy with donor lymphocyte infusion and recipient dendritic cell vaccination in multiple myeloma.
Henriëtte Levenga, Nicolaas Schaap, Frans Maas, Bennie Esendam, Hanny Fredrix

Biol Blood Marrow Transplant· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloid leukemic progenitor cells can be specifically targeted by minor histocompatibility antigen LRH-1-reactive cytotoxic T cells.
Wieger J Norde, Ingrid M Overes, Frans Maas, Hanny Fredrix, Johanna C M Vos

Blood· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia.
Björn de Rijke, Agnes van Horssen-Zoetbrood, Jeffrey M Beekman, Britt Otterud, Frans Maas

J Clin Invest· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of the HA-1 gene product at the RNA level; relevance for immunotherapy of hematological malignancies.
Martina Wilke, Harry Dolstra, Frans Maas, Jos Pool, Rolf Brouwer

Hematol J· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bi-directional allelic recognition of the human minor histocompatibility antigen HB-1 by cytotoxic T lymphocytes.
Harry Dolstra, Björn de Rijke, Hanny Fredrix, Antonio Balas, Frans Maas

Eur J Immunol· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis